Laboratório Associado IBMC INEB

ON THE NEWS
A bioartificial pancreas was generated in the labs of the University of Coimbra, with the collaboration of i3S researchers Pedro Granja, Cristina Barrias and Bruno Sarmento. The ultimate goal is to provide an insulin shot-free life to diabetes patients.

Universidade de Coimbra desenvolve pâncreas bioartificial para tratar diabetes A equipa "focou-se em melhorar as propriedades biológicas" do dispositivo artificial. A ideia é criar um tratamento para tratar a diabetes, que afeta mais de um milhão de pessoas em Portugal.

ON THE NEWS:
i3S Researcher Jorge Ferreira, from Maiato’s lab, received the Montepio Award from the Lisbon Academy of Sciences for the study of proteins involved in the cell division process.
https://noticias.up.pt/academia-das-ciencias-de-lisboa-distingue-investigacao-da-u-porto/

Academia das Ciências de Lisboa distingue investigação da U.Porto Jorge Ferreira (i3S/FMUP) e Paula Gonçalves (FCUP) venceram a 1.ª edição do Prémio Montepio, atribuído às melhores dissertações de Doutoramento desenvolvidas em universidades portuguesas.

ON THE NEWS:
Helder Maiato, i3S researcher, elected EMBO (European Molecular Biology Organization) member.

Investigador do i3S eleito para a Organização Europeia de Biologia Molecular Helder Maiato foi escolhido pelo mérito e a excelência do trabalho científico que tem desenvolvido nos últimos anos no domínio da biologia molecular.

Next Thursday, on May 25th, the exhibition "Enhancement: MAKING SENSE" is opening not at a gallery, but right here at i3S. The program includes the first session of a series of debates on enhancement. This first session is taking place at Auditorium Corino de Andrade, from 19h to 20h, and the discussion will revolve around drugs and creativity in a talk entitled "The Night of Alice".
Alexandre Quintanilha is at the helm of the debate, in which participate Teresa Summavielle - with the talk "L*D adventures underground" - and Jonathan Lewis - with a view on "Drugs in Huxley".
Following the debate, a cocktail serves as the perfect ending to the inauguration.
Everyone is invited!

EVENT
Next Wednesday, on May 25th, the exhibition "Enhancement: MAKING SENSE" is opening not at a gallery, but right here at i3S. The program includes the first session of a series of debates on enhancement. This first session is taking place at Auditorium Corino de Andrade, from 19h to 20h, and the discussion will revolve around drugs and creativity in a talk entitled "The Night of Alice".
Alexandre Quintanilha is at the helm of the debate, in which participate Teresa Summavielle - with the talk "L*D adventures underground" - and Jonathan Lewis - with a view on "The Doors of Perception - Huxley's visionary experience".
Following the debate, a cocktail serves as the perfect ending to the inauguration.
Everyone is invited!
....................................................................................................
EVENTO
A exposição "Enhancement: MAKING SENSE" vai ser inaugurada no i3S no dia 25 de maio de 2016. O programa inclui a primeira de uma série de debates sobre "enhancement". O primeiro debate, a 25 de maio, das 19h às 20h será a "Noite da Alice" sobre drogras e criatividade e terá lugar no auditório Corino de Andrade.
Alexandre Quintanilha irá moderar o debate que conta com as intervenções de Teresa Summavielle, "L*D adventures underground", e Jonathan Lewis, "The Doors of Perception - a experiência visionária de Huxley".
A inauguração da exposição decorrerá no fim do debate com um pequeno cocktail. Estão todos convidados.

As células têm um padrão geométrico que avisa para o risco de cancro Cientistas portugueses criaram um método de análise automática de imagens microscópicas de células que permite identificar padrões de risco.

Since this year's January and until the end of 2019, a new treatment prospect is being outlined for all patients suffering from Rheumatoid Arthritis (RA). The internacional project , in which a few i3S researchers partake, aims to increase the efficiency of RA therapy using folate-based nanodevices. The project's pre-clinical phase is under way and clinical trials will ensue.
We'll keep you posted!

FOLSMART and the strive for a more efficient Rheumatoid Arthritis treatment Following in the footsteps of NANOFOL, FOLSMART is a project that aims to improve the treatments for Rheumatoid Arthritis (RA) and focuses on folate-targeted devices for the activation of macrophages. The translation of laboratory-based medication into phase 1 clinical trials is also a major goal fo…

YOU MAY BE INTERESTED
Applications are now open for a post-doctoral fellowship in the project "RESOLVE - Specific Responses to Overcome Obstacles that Limit Efficacy in Knowledge Valorisation".
More info: http://bit.ly/1MgMu6H

ON THE NEWS
A team led by i3S researcher Bruno Sarmento has just been awarded a €30k grant by the Gilead GÉNESE Program to further his work on nanomedicine, with the ultimate goal of developing a product capable of preventing women from contracting HIV/AIDS through vaginal contact. The team includes researcher Pedro Granja and PhD students Rute Nunes and Francisca Araújo, also working at i3S.

Investigadores do i3S inovam na prevenção do VIH/SIDA Projeto liderado por Bruno Sarmento foi contemplado com uma bolsa de investigação de 30 mil euros, atribuída no âmbito do Programa Gilead GÉNESE 2015.

Centro de Ciência Viva Rómulo de Carvalho has been organizing talks on the frontiers of Science targeted at the lay public, in an effort to bridge the two communities.
i3S invites you to attend the April 7th lecture entitled "Determinism and susceptibility: a two-faced frontier in new genetics", a topic addressed by Professor Claudio Sunkel.

ON THE NEWS
José Bessa is the Researcher of the Month for the magazine Prevenir.

ON THE NEWS
The April's issue of Super Interessante devotes a few pages to neuroenhancement, "smart drugs" and technologies designed to improve our cognitive functions. Nerri Project members Teresa Summavielle and Maria Rui Vilar Correia talk about what is already available, the direct and collateral risks, and the importance of being well-informed to partake in a timely discussion.

We let you know back in February that Ciência Viva is promoting a series of talks on Life Sciences Ethics every last Thursday of the month. Tomorrow, March 31st, the topic under discussion is Synthetic Biology, its potential uses and risks. i3S researcher Paula Tamagnini is one of the speakers, who joins José Matos (INIAV and Portuguese Society of Biologists) and Pedro Fevereiro (ITQB).
The session takes place at Pavilhão do Conhecimento and it's scheduled for 19h30.
More info: http://www.cienciaviva.pt/diac